Catherine London is an executive vice president and head of corporate communications and investor relations at Bioasis Technologies, Inc. London has more than 22 years of experience in the pharmaceutical and healthcare industries and has successfully led large, global teams and strategic plans. London most recently served as the head of corporate communications at Purdue Pharma. Prior to Purdue Pharma, London served in director-level roles in corporate and product communications at Alexion Pharmaceuticals, Inc. and Boehringer Ingelheim Pharmaceuticals, Inc. In these roles, her responsibilities included executive, corporate, product and financial communications, government and policy communications and business communications. London has also held senior leadership roles at global consulting firms such as Ruder Finn and the Chandler Chicco Companies, an inVentiv Health Company, which includes Chamberlain, Chandler Chicco and BioSector2.
London began her career as a reporter and editor working at print and broadcast outlets in various U.S. markets before taking a turn as a science journal editor and eventually making the transition to public affairs at the American Diabetes Association in Washington, D.C. London holds a bachelor of arts degree in journalism from Auburn University in Auburn, Ala.